Intervention research supported by NIMH includes efficacy and effectiveness studies of all therapeutic modalities, including ECT. The benefit-risk ratio of different electrode placements and stimulus dosing
+(5) and predictors of response
+(6) are among the clinical reports published this decade from NIMH-funded studies of ECT. Readers of the
Journal will recall that the last article
+(6) 3 years ago described the initial stage of an ongoing, three-site clinical trial comparing two medication regimens and placebo as maintenance treatment after a successful course of ECT, which without effective follow-up treatment has a distressingly high early relapse rate
+(2). Another clinical trial in four centers will examine the decades-old empirical practice of continuation ECT to prevent relapse, particularly when other strategies have failed to sustain ECT-induced remission
+(2,
+4).